CAD 5.42
(0.37%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 769.64 Million USD | -22.77% |
2022 | 996.5 Million USD | 19.78% |
2021 | 831.95 Million USD | 463.83% |
2020 | 147.55 Million USD | -24.85% |
2019 | 196.35 Million USD | 1380.42% |
2018 | 13.26 Million CAD | 9.59% |
2017 | 12.1 Million CAD | 122.41% |
2016 | 5.44 Million CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 770.25 Million USD | -0.36% |
2024 Q2 | 775.67 Million USD | -0.29% |
2023 FY | 769.64 Million USD | -22.77% |
2023 Q2 | 813.8 Million USD | -18.13% |
2023 Q4 | 769.64 Million USD | 2.86% |
2023 Q1 | 994 Million USD | -0.25% |
2023 Q3 | 748.21 Million USD | -8.06% |
2022 Q4 | 996.5 Million USD | 8.77% |
2022 FY | 996.5 Million USD | 19.78% |
2022 Q1 | 913.95 Million USD | 9.86% |
2022 Q2 | 931.36 Million USD | 1.91% |
2022 Q3 | 916.13 Million USD | -1.64% |
2021 Q1 | 167.06 Million USD | 13.22% |
2021 FY | 831.95 Million USD | 463.83% |
2021 Q4 | 831.95 Million USD | 166.32% |
2021 Q3 | 312.39 Million USD | 11.83% |
2021 Q2 | 279.34 Million USD | 67.21% |
2020 FY | 147.55 Million USD | -24.85% |
2020 Q4 | 147.55 Million USD | -39.65% |
2020 Q3 | 244.49 Million USD | 4.54% |
2020 Q2 | 233.87 Million USD | 7.85% |
2020 Q1 | 216.83 Million USD | 10.43% |
2019 Q2 | 101.58 Million USD | 117.26% |
2019 Q4 | 196.35 Million USD | 83.38% |
2019 Q3 | 107.07 Million USD | 5.41% |
2019 Q1 | 46.75 Million CAD | 252.52% |
2019 FY | 196.35 Million USD | 1380.42% |
2018 Q2 | 27.07 Million CAD | 0.0% |
2018 Q4 | 13.26 Million CAD | -12.34% |
2018 FY | 13.26 Million CAD | 9.59% |
2018 Q1 | - CAD | -100.0% |
2018 Q3 | 15.12 Million CAD | -44.11% |
2017 Q4 | 12.1 Million CAD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | 12.1 Million CAD | 122.41% |
2016 Q4 | - CAD | 0.0% |
2016 FY | 5.44 Million CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aion Therapeutic Inc. | - CAD | -Infinity% |
Ayurcann Holdings Corp. | 129.01 Thousand CAD | -596432.294% |
Blueberries Medical Corp. | 11.04 Thousand CAD | -6970014.11% |
The BC Bud Corporation | - CAD | -Infinity% |
BioNxt Solutions Inc. | - CAD | -Infinity% |
CordovaCann Corp. | 3.31 Million CAD | -23107.148% |
Christina Lake Cannabis Corp. | 4.48 Million CAD | -17047.921% |
Captor Capital Corp. | 5.47 Million CAD | -13950.169% |
City View Green Holdings Inc. | - CAD | -Infinity% |
1CM Inc. | 4.14 Million CAD | -18458.238% |
Global Hemp Group Inc. | 3.55 Million CAD | -21539.616% |
Greenway Greenhouse Cannabis Corporation | 7.37 Million CAD | -10340.301% |
IM Cannabis Corp. | 394 Thousand CAD | -195240.102% |
Lobe Sciences Ltd. | - CAD | -Infinity% |
Maple Leaf Green World Inc. | - CAD | -Infinity% |
Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
Nextleaf Solutions Ltd. | 384.69 Thousand CAD | -199966.027% |
Ovation Science Inc. | 18.26 Thousand CAD | -4213180.78% |
Pharmadrug Inc. | - CAD | -Infinity% |
Captiva Verde Wellness Corp. | - CAD | -Infinity% |
RAMM Pharma Corp. | 179.76 Thousand CAD | -428048.643% |
RIV Capital Inc. | 144.15 Million CAD | -433.899% |
Revive Therapeutics Ltd. | - CAD | -Infinity% |
Red White & Bloom Brands Inc. | 21.42 Million CAD | -3492.643% |
SLANG Worldwide Inc. | 3.16 Million CAD | -24199.055% |
1933 Industries Inc. | 12.57 Million CAD | -6020.219% |
Red Light Holland Corp. | 291.08 Thousand CAD | -264304.777% |
Top Strike Resources Corp. | 1.7 Million CAD | -45137.071% |
Xebra Brands Ltd. | - CAD | -Infinity% |
Adastra Holdings Ltd. | 147.51 Thousand CAD | -521643.846% |